Dawn Christine Maroney Sells 30,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $15.99, for a total value of $479,700.00. Following the sale, the president now owns 2,417,700 shares of the company’s stock, valued at $38,659,023. This represents a 1.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.43, for a total transaction of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total transaction of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.72, for a total transaction of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Price Performance

NASDAQ ALHC opened at $16.74 on Wednesday. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The firm has a market capitalization of $3.21 billion, a PE ratio of -21.74 and a beta of 1.49. Alignment Healthcare, Inc. has a 12 month low of $4.46 and a 12 month high of $17.24. The company’s 50 day simple moving average is $14.58 and its 200 day simple moving average is $12.56.

Wall Street Analyst Weigh In

ALHC has been the topic of a number of recent research reports. Stifel Nicolaus raised their target price on shares of Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, February 28th. Bank of America lifted their price target on Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a report on Tuesday, March 4th. Barclays lifted their price target on Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a report on Friday, February 28th. William Blair reaffirmed an “outperform” rating on shares of Alignment Healthcare in a report on Friday, February 28th. Finally, Piper Sandler lifted their price target on Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $14.83.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Verition Fund Management LLC grew its position in Alignment Healthcare by 85.3% in the third quarter. Verition Fund Management LLC now owns 121,180 shares of the company’s stock worth $1,432,000 after buying an additional 55,771 shares during the last quarter. JPMorgan Chase & Co. grew its position in Alignment Healthcare by 249.3% in the third quarter. JPMorgan Chase & Co. now owns 288,219 shares of the company’s stock worth $3,407,000 after buying an additional 205,705 shares during the last quarter. Principal Financial Group Inc. grew its position in Alignment Healthcare by 1,335.1% in the third quarter. Principal Financial Group Inc. now owns 194,043 shares of the company’s stock worth $2,294,000 after buying an additional 180,522 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in Alignment Healthcare by 132.2% in the third quarter. The Manufacturers Life Insurance Company now owns 128,933 shares of the company’s stock worth $1,524,000 after buying an additional 73,402 shares during the last quarter. Finally, Barclays PLC grew its position in Alignment Healthcare by 144.1% in the third quarter. Barclays PLC now owns 193,446 shares of the company’s stock worth $2,287,000 after buying an additional 114,191 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.